Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 12.76M | $ 95.91M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 12.76M | $ 95.91M | $ 0.00 | $ 0.00 |
| Operating Income | $ -165.73M | $ -3.32M | $ -30.73M | $ -5.43M |
| EBITDA | $ -176.86M | $ -3.31M | $ -30.73M | $ -5.43M |
| Net Income | $ -176.94M | $ -21.14M | $ -36.71M | $ -5.75M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 340.45M | $ 438.52M | $ 53.09M | $ 7.86M |
| Total Assets | $ 347.10M | $ 531.58M | $ 59.78M | $ 9.23M |
| Total Debt | $ 60.00K | $ 118.00K | $ 164.00K | $ 11.65M |
| Net Debt | $ -340.39M | $ -438.40M | $ -52.93M | $ 3.79M |
| Total Liabilities | $ 58.70M | $ 47.06M | $ 9.99M | $ 12.81M |
| Stockholders' Equity | $ 288.39M | $ 484.52M | $ 49.79M | $ -3.58M |
| Cash Flow | ||||
| Free Cash Flow | $ -141.24M | $ 7.96M | $ -25.18M | $ -5.98M |
| Operating Cash Flow | $ -141.22M | $ 7.97M | $ -25.16M | $ -5.97M |
| Investing Cash Flow | $ -24.00K | $ 715.00K | $ -20.00K | $ -13.00K |
| Financing Cash Flow | $ 8.91M | $ 375.18M | $ 68.99M | $ 11.32M |
NewAmsterdam Pharma Company Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.